MedTrace Logo

COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)

NCT04818853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2026-01-16

No results posted yet for this study

Summary

The purpose of this study is to identify the number of individuals with severe CoVID who require ventilator support and who develop serious fungal infections. The study is an observational study, meaning that we are not providing any intervention that does not involve usual standard of care. Our chief goal is to find evidence of fungal infection by using traditional, approved methods of diagnosis, but by applying these methods in the same way and frequency among all study participants. We will be looking especially for evidence of a fungal infection known as Aspergillus, which can causes a serious lung infection called invasive aspergillosis (IA).

Conditions

Interventions

OTHER

Observation to monitor patients for these infections

We will be receiving discarded specimens weekly. From these we are going to identify these various potential infections.

Sponsors & Collaborators

Principal Investigators

  • Peter Pappas, MD · The University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-09
Primary Completion
2022-07-20
Completion
2023-01-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04818853 on ClinicalTrials.gov